|
|
 |
|
Viewing report
|
|
|
|
Molecular Imaging Agents: Technology, Targets and Commercial Outlook
Greystone Associates, July 2010
Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare conditions that can be effectively imaged noninvasively is expanding as a result of these innovative detection technologies. Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which the reagents take on new importance.
Highlights
- Analyzes and assesses emerging imaging diagnostic candidates, their capabilities, benefits, limitations and potential
- Profiles development-stage imaging agents and examines their clinical status and commercial prospects
- Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets
- Profiles market participants, their development activity and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D and Clinical Practice, and Informatics and Regulatory Requirements
Molecular Diagnostics - Technologies, Markets and Companies
Biomarkers - Global Strategic Business Report
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010
The Executive Guide to Molecular Imaging
Picture This: Revealing Trends for a More Robust Diagnostic Imaging Industry
Diagnostics Bundle
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
|
|
|
